Aperio Technologies, a digital pathology company for the healthcare and life sciences industry, has completed a $20 million series C financing.
HLM Venture Partners, a Boston and San Francisco-based healthcare venture capital firm, led the round. Joining HLM in the series C funding are existing investors Galen Partners and Advanced Technology Ventures, and new investors Acadia Woods Partners and BlackRock Alternative Advisors, according to the Vista, Calif.-based Aperio.
Aperio said it will use the new capital to accelerate clinical market development, expand sales and operations and develop new products in support of its patented digital pathology system, which includes its linear array-based ScanScope slide scanning systems, Spectrum information management software, image analysis applications and professional services.
With this equity financing round, the company said Martin R. Felsenthal, a partner at HLM Venture Partners, joins the Aperio board of directors.